Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

NCT06792734 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: BTM-3566

Sponsor

Bantam Pharmaceuticals